Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Human IL-1 RAcP/IL-1 R3 Protein

Catalog No. 9176CP100
Change view
Click to view available options
:
Recombinant Human IL-1 RAcP/IL-1 R3 Protein, Carrier-Free
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No.
91-76C-P100 Recombinant Human IL-1 RAcP/IL-1 R3 Protein, Carrier-Free
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 91-76C-P100 Supplier R&D Systems™ Supplier No. 9176CP100
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human IL-1 RAcP/IL-1 R3 Protein is derived from HEK293. The Recombinant Human IL-1 RAcP/IL-1 R3 Protein has been validated for the following applications: Bioactivity.

Order Info

The product is shipped at ambient temperature.

Specifications

Accession Number Q9NPH3
For Use With (Application) Bioactivity
Formulation Lyophilized from a 0.2μm filtered solution in PBS.
Gene ID (Entrez) 3556
Molecular Weight (g/mol) 40 kDa
Name C3orf13IL-1RAcPIL1R3Interleukin-1 receptor 3, FLJ37788, IL-1 R3, IL-1 receptor accessory protein, IL-1R3, IL-1R-3, IL1RAcP, IL-1RAcP, IL1RAP, interleukin 1 receptor accessory protein, interleukin-1 receptor accessory protein, interleukin-1 receptor access
Quantity 100μg
Source Human embryonic kidney cell,HEK293-derived human IL-1 RAcP/IL-1 R3 protein Ser21-Glu359,with a C-terminal 6-His tag
Storage Requirements Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
Regulatory Status RUO
Endotoxin Concentration <0.10 EU per 1μg of protein by LAL method
Biological Activity Measured by its ability to inhibit IL-1 alpha -induced IL-8 secretion in HepG2 human hepatocellular carcinoma cells. The ED50 for this effect is 0.8‑4 μg/mL in the presence of 1 μg/mL of recombinant human (rh) IL-1 R2 Fc Chimera and 50 pg/mL rhIL-1 alp
Conjugate Unconjugated
Species Human
Recombinant Recombinant
Purity or Quality Grade >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.